Robins Kaplan Named “Recommended Firm” For Hatch-Waxman Litigation in 2021

Four Partners Named “Life Science Stars”

October 26, 2021

Robins Kaplan LLP is pleased to announce that LMG Life Sciences has recommended the firm as a top Hatch-Waxman patent litigation firm nationwide for generic pharmaceutical companies. In addition, Jake M. Holdreith, Jeffrey Alan Hovden, Oren D. Langer, and Ronald J. Schutz have been named “Life Science Stars.”

  • Jake Holdreith is a member of the firm’s Executive Board and the leader of the firm’s life sciences group. He has tried jury cases to multi-million dollar verdicts and resolved complex cases at all stages of litigation. He is a skilled and creative strategist and business counselor who can cut to the heart of a matter in the boardroom and the courtroom. Holdreith is known for work in in the pharmaceutical, chemical, and electronics industries and has handled cases in the United States, Europe, and Asia.
  • Jeff Hovden practices in the area of patent litigation, with a focus on generic pharmaceutical patent cases under the Hatch-Waxman Act and within the biotechnology industry. He has litigated numerous patent infringement and invalidity actions, including many cases involving top-selling worldwide prescription drugs for both generic and name-brand clients. He routinely advises clients on their intellectual property portfolios and has extensive experience with the Food, Drug, and Cosmetic Act's drug-approval provisions and their attendant regulations.
  • Oren Langer is Managing Partner of the firm’s New York office and a member of the Executive Board. He focuses his practice on intellectual property and technology litigation. His experience spans various industries, including pharmaceuticals (under the Hatch-Waxman Act regulatory framework), chemicals, telecommunications, video gaming, and retail services. He also advises clients on licensing negotiations and campaigns, and monetizing intellectual property in anticipation of prospective mergers or acquisitions.
  • Ronald Schutz is chair of the firm’s Executive Board. He is a fellow of the American College of Trial Lawyers and has been recognized by many legal organizations and publications as one of the top lawyers in the country, including The National Law Journal, which named him one of the “Top 10 Winning Litigators in the United States.” He has won a nine-figure and multiple eight-figure jury verdicts, and has secured victories against behemoths such as Apple, Clear Channel, Sony, and Canon.

Jake M. Holdreith

Partner

Managing Partner, Minneapolis Office
Member of Executive Board

Oren D. Langer

Partner

Managing Partner, New York Office

Ronald J. Schutz

Partner

Immediate Past Chairman
Member of Executive Board

Related Publications

First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
March 25, 2024
Endo Ventures Unlimited Co. v. Nexus Pharms. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 22, 2024
Mallinckrodt plc v. Airgas Therapeutics LLC
GENERICally Speaking Hatch Waxman Bulletin
March 8, 2024
UCB, Inc. v. Mylan Techs. Inc.
GENERICally Speaking Hatch Waxman Bulletin
March 5, 2024
Genentech, Inc. v. Sandoz, Inc.
GENERICally Speaking Hatch Waxman Bulletin
Back to Top